NCT02008227 2019-12-20
OAK
Hoffmann-La Roche
Phase 3 Completed
Clinical Trials
3 trialsNCT01351415 2017-09-18
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Phase 3 Completed
NCT01204697 2015-11-16
A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)
Hoffmann-La Roche
Phase 2 Completed